This system is currently in its second edition (2023) and is a standard tool in cytopathology . If you'd like, I can provide:
The sample did not have enough cells to make a diagnosis. II: Benign: High probability of being non-cancerous. The Bethesda System for Reporting Thyroid Cytop...
Indeterminate; high risk of being a follicular tumor, often requiring surgery to differentiate. This system is currently in its second edition
It provides clearer guidelines for indeterminate cases (III and IV), which often helped reduce unnecessary thyroidectomies. surveillance vs. surgery). Indeterminate
Each category helps clinicians understand the likelihood of malignancy to guide treatment (e.g., surveillance vs. surgery).
Indeterminate; the cells look unusual, but not definitely cancerous.
It ensures that a "suspicious" result means the same thing, regardless of which lab processed it.